ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,743Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1269

$883K Total Retail Price of All Prescriptions

Rank: 37 out of 1269

534 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
63% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maryland
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 534 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 534 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 15,736 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 671 645 1 5
LEVOTHYROXINE SODIUM 667 633 2 4
METOPROLOL TARTRATE 537 500 3 6
TRAMADOL HCL 480 464 4 16
LISINOPRIL 466 424 5 1
SIMVASTATIN 388 375 6 3
AMLODIPINE BESYLATE 384 353 7 2
POTASSIUM CHLORIDE 378 372 8 26
OMEPRAZOLE 377 356 9 8
JANTOVEN 347 327 10 52
DONEPEZIL HCL 288 288 11 22
SERTRALINE HCL 239 216 12 23
CITALOPRAM HBR 239 216 12 21
WARFARIN SODIUM 230 215 14 12
LOSARTAN POTASSIUM 211 205 15 15
HYDROCODONE-ACETAMINOPHEN 207 192 S3 16 20
METOPROLOL SUCCINATE 192 179 17 13
GABAPENTIN 190 164 18 17
ATENOLOL 186 179 19 14
HYDROCHLOROTHIAZIDE 184 183 20 10
RISPERIDONE 176 169 21 43
DIGOXIN 169 163 22 62
NYSTATIN-TRIAMCINOLONE 163 162 23 190
QUETIAPINE FUMARATE 159 159 24 53
METFORMIN HCL 157 143 25 9
CLOPIDOGREL 155 153 26 32
LOVASTATIN 153 147 27 30
TAMSULOSIN HCL 150 150 28 31
ATORVASTATIN CALCIUM 146 139 29 7
LANTUS 140 127 30 39
ALLOPURINOL 136 135 31 49
GLIPIZIDE 136 136 31 37
NYSTATIN 120 112 33 119
PANTOPRAZOLE SODIUM 117 104 34 18
NAMENDA 117 117 34 38
NITROGLYCERIN PATCH 114 114 36 114
ROPINIROLE HCL 112 111 37 151
SPIRONOLACTONE 106 101 38 77
ENALAPRIL MALEATE 106 105 38 79
CARVEDILOL 100 92 40 29
AZITHROMYCIN 99 88 41 42
LYRICA 98 98 42 92
PLAVIX 98 98 42 47
CEPHALEXIN 96 87 44 113
POLYETHYLENE GLYCOL 3350 96 92 44 50
ZOLPIDEM TARTRATE 96 81 44 19
QUINAPRIL HCL 95 95 47 167
IPRATROPIUM-ALBUTEROL 94 85 48 86
ESCITALOPRAM OXALATE 93 85 49 58
OXYCODONE-ACETAMINOPHEN 92 55 S2 50 44
LEVETIRACETAM 86 59 51 55
CIPROFLOXACIN HCL 85 79 52 66
DIOVAN 84 73 53 35
MIRTAZAPINE 82 79 54 24
SYNTHROID 80 80 55 72
PREDNISONE 79 77 56 45
PROMETHAZINE HCL 79 72 R 56 149
PAROXETINE HCL 79 79 56 71
FAMOTIDINE 78 77 59 85
RANITIDINE HCL 78 76 59 27
LOPERAMIDE 76 74 61 212
CARBIDOPA-LEVODOPA 74 74 62 78
FENTANYL 71 71 S2 63 105
GLIPIZIDE XL 66 66 64 125
TRIAMTERENE-HCTZ 66 66 64 69
SPIRIVA 64 55 66 64
LANSOPRAZOLE 64 55 66 120
CLOTRIMAZOLE-BETAMETHASONE 63 60 68 175
LISINOPRIL-HYDROCHLOROTHIAZIDE 63 59 68 33
ISOSORBIDE MONONITRATE ER 62 62 70 63
NOVOLOG 61 56 71 82
NOVOLIN R 58 58 72 211
TRICOR 57 40 73 152
CYCLOBENZAPRINE HCL 57 50 R 73 93
CELEBREX 56 56 75 95
CLONIDINE HCL 54 50 76 51
PRAVASTATIN SODIUM 53 48 77 11
MECLIZINE HCL 53 52 77 140
HYDROXYZINE HCL 52 52 R 79 274
LEVOFLOXACIN 52 50 79 75
FLUOCINONIDE 52 52 79 255
ALENDRONATE SODIUM 51 51 82 28
HYDROCORTISONE VALERATE 51 50 82 275
LACTULOSE 50 50 84 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 29, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.